Reduced acetylcholine receptor density, morphological remodeling, and butyrylcholinesterase activity can sustain muscle function in acetylcholinesterase knockout mice

被引:43
作者
Adler, M [1 ]
Manley, HA
Purcell, AL
Deshpande, SS
Hamilton, TA
Kan, RK
Oyler, G
Lockridge, O
Duysen, EG
Sheridan, RE
机构
[1] USA, Med Res Inst Chem Def, Neurotoxicol Branch, Div Pharmacol, Aberdeen Proving Ground, MD 21010 USA
[2] Battelle Eastern Reg Technol Ctr, Aberdeen, MD USA
[3] USA, Med Res Inst Chem Def, Comparat Pathol Branch, Div Comparat Med, Aberdeen Proving Ground, MD 21010 USA
[4] Univ Maryland, Dept Neurol, Sch Med, Baltimore, MD 21201 USA
[5] Vet Affairs Med Ctr, Baltimore, MD USA
[6] Univ Nebraska, Med Ctr, Eppley Inst, Dept Biochem & Mol Biol, Omaha, NE 68198 USA
关键词
acetylcholine; acetylcholine receptor; acetylcholinesterase; butyrylcholinesterase; diaphragm; knockout mice; muscle tension;
D O I
10.1002/mus.20099
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Nerve-evoked contractions were studied in vitro in phrenic nerve-hemidiaphragm preparations from strain 129X1 acetylcholinesterase knockout (AChE(-/-)) mice and their wild-type littermates (AChE(+/+)). The AChE(-/-) mice fail to express AChE but have normal levels of butyrylcholinesterase (BChE) and can survive into adulthood. Twitch tensions elicited in diaphragms of AChE(-/-) mice by single supramaximal Stimuli had larger amplitudes and slower rise and decay times than did those in wild-type animals. In AChE(-/-) preparations, repetitive stimulation at frequencies of 20 and 50 Hz and at 200 and 400 Hz produced decremental muscle tensions; however, stimulation at 70 and 100 Hz resulted in little or no loss of tension during trains. Muscles from AChE(+/+) mice maintained tension at all frequencies examined but exhibited tetanic fade after exposure to the selective AChE inhibitor 1,5-bis(4-allyldimethyl-ammoniumphenyl)pentane-3-one (BW 284C51). The ability of diaphragm muscles from AChE(-/-) mice to maintain tension at 70 and 100 Hz suggests a partial compensation for impairment of acetylcholine (ACh) hydrolysis. Three mechanisms-including a reliance on BChE activity for termination of ACh action, downregulation of nicotinic acetylcholine receptors (nAChRs), and morphological remodeling of the endplate region-were identified. Studies of neuromuscular transmission in this model system provide an excellent opportunity to evaluate the role of AChE without complications arising from use of inhibitors.
引用
收藏
页码:317 / 327
页数:11
相关论文
共 36 条
[1]   INVITRO EFFECTS OF SOMAN ON BRONCHIAL SMOOTH-MUSCLE [J].
AAS, P ;
VEITEBERG, T ;
FONNUM, F .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (11) :1793-1799
[2]   MECHANISM OF SOMAN-INDUCED CONTRACTIONS IN CANINE TRACHEAL SMOOTH-MUSCLE [J].
ADLER, M ;
MOORE, DH ;
FILBERT, MG .
ARCHIVES OF TOXICOLOGY, 1992, 66 (03) :204-210
[3]   REGULATION OF ACETYLCHOLINE HYDROLYSIS IN CANINE TRACHEAL SMOOTH-MUSCLE [J].
ADLER, M ;
REUTTER, SA ;
MOORE, DH ;
FILBERT, MG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 205 (01) :73-79
[4]  
ADLER M, 1991, ARCH INT PHARMACOD T, V312, P126
[5]   TURNOVER OF TRANSMITTER AND SYNAPTIC VESICLES AT FROG NEUROMUSCULAR JUNCTION [J].
CECCARELLI, B ;
HURLBUT, WP ;
MAURO, A .
JOURNAL OF CELL BIOLOGY, 1973, 57 (02) :499-524
[6]   NEUROPHYSIOLOGICAL CONCOMITANTS OF SOMAN-INDUCED RESPIRATORY DEPRESSION IN AWAKE, BEHAVING GUINEA-PIGS [J].
CHANG, FCT ;
FOSTER, RE ;
BEERS, ET ;
RICKETT, DL ;
FILBERT, MG .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1990, 102 (02) :233-250
[7]   Respiratory survival mechanisms in acetylcholinesterase knockout mouse [J].
Chatonnet, F ;
Boudinot, É ;
Chatonnet, A ;
Taysse, L ;
Daulon, S ;
Champagnat, J ;
Foutz, AS .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2003, 18 (06) :1419-1427
[8]   NATURE OF THE ANTICHOLINESTERASE-INDUCED REPETITIVE RESPONSE OF RAT AND MOUSE STRIATED-MUSCLE TO SINGLE NERVE STIMULI [J].
CLARK, AL ;
HOBBIGER, F ;
TERRAR, DA .
JOURNAL OF PHYSIOLOGY-LONDON, 1984, 349 (APR) :157-166
[9]   ACTIONS OF TUBOCURARINE AT THE FROG NEUROMUSCULAR-JUNCTION [J].
COLQUHOUN, D ;
DREYER, F ;
SHERIDAN, RE .
JOURNAL OF PHYSIOLOGY-LONDON, 1979, 293 (AUG) :247-284
[10]  
Couteaux R, 1974, Adv Cytopharmacol, V2, P369